Stratification of Chronic Alcoholic Liver Diseases (SCALE Study)
NCT ID: NCT03295812
Last Updated: 2018-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2017-11-16
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China
NCT03281265
Acute on Chronic Liver Failure in Cirrhotic Patients at Assiut University Hospitals
NCT06142968
Nomogram Analysis for HBV Related Acute-on-chronic Liver Failure
NCT03992898
Prognosis of Patients With Acute-on-chronic Liver Failure
NCT05393453
Platelet Transfusion in HBV-related acute-on Chronic Liver Failure
NCT03713489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standard therapy
standard therapy,non-interventional study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. \>40g/d for male and \>20g/d for female, at least for 5 years;
2. \>50g/d for at least 6 months;
2. Liver injury (at least one of the followings):
1. AST\>1.0 ULN and AST\>ALT;
2. TBIL\>2.0mg/dl;
3. Ascites;
4. Hepatic encephalopathy;
5. Esophageal variceal bleeding;
6. Hypersplenism
Exclusion Criteria
2. Other etiologies rather than alcoholic liver disease, including but not limited to the followings:
1. Acute or chronic virologic hepatitis: Hepatitis A-E, Hepatitis caused by CMV,EBV, etc.
2. Autoimmune hepatitis, including PSC, PBC, AIH, IgG4 related liver disease
3. Inherited metabolic liver diseases: Wilson disease;
4. Others: Schistosomiasis
3. HIV antibody positive;
4. Malignancies including but not limited to HCC;
5. Pregnancy;
6. Hospital stay less than 24h;
7. Refuse to sigh the informed consent;
8. Combined with other improper situations determined by investigators.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanfang Hospital, Southern Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jinjun Chen
Role: PRINCIPAL_INVESTIGATOR
Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanfang Hospital
Guangzhou, Guangdong, China
People's hospital of Yangshan
Qingyuan, Guangdong, China
Dongguan dalang hospital
Dongguan, , China
People's hospital of Foshan Nanhai District
Foshan, , China
The First People's Hospital of Foshan
Foshan, , China
Guangdong General Hospital
Guangzhou, , China
Guangzhou Eighth People's Hospital
Guangzhou, , China
The First Affiliated Hospital,Guangzhou University of Chinese Medicine
Guangzhou, , China
The First Affiliated Hospital,Jinan University
Guangzhou, , China
Huizhou Central Hospital
Huizhou, , China
Huizhou Hospital of Traditional Chinese Medicine
Huizhou, , China
The First People's Hospital of Huizhou
Huizhou, , China
The Sixth People's Hospital of Huizhou
Huizhou, , China
The Third People's hospital of Huizhou
Huizhou, , China
People's Hospital of Enping
Jiangmen, , China
Kaiping Central Hospital
Kaiping, , China
The Second People's Hospital of Yuebei
Shaoguan, , China
Peking University Shenzhen Hospital
Shenzhen, , China
Shenzhen Third People's Hospital
Shenzhen, , China
Shunde Hospital of Southern Medical University
Shunde, , China
Yangjiang Public Health Hospital
Yangjiang, , China
People's Hospital of Yingde City
Yingde, , China
Nongken Central Hospital
Zhanjiang, , China
The First People's Hospital of Zhaoqing
Zhaoqing, , China
Zhaoqing No.2 People's Hospital
Zhaoqing, , China
Zhongshan Second People's Hospital
Zhongshan, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yan Chen
Role: primary
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.